XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.3
DEBT AND CREDIT FACILITIES (Tables)
9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Debt Obligations
A summary of the Company’s debt obligations on its consolidated balance sheets is set forth below:
At September 30, 2025At December 31, 2024
Fair Value
Carrying Value
Fair Value
Carrying Value
5.950% Senior Notes due 2035 (DaVinci) (1)
$308,643 $296,890 $— $— 
5.800% Senior Notes due 2035
524,145 493,601 — — 
5.750% Senior Notes due 2033
788,295 742,772 755,693 742,068 
3.600% Senior Notes due 2029
391,456 396,737 376,816 396,051 
3.450% Senior Notes due 2027
296,769 299,135 290,070 298,765 
3.700% Senior Notes due 2025 (2)
— — 299,550 299,908 
4.750% Senior Notes due 2025 (DaVinci) (1) (3)
— — 149,363 149,897 
Total senior notes2,309,308 2,229,135 1,871,492 1,886,689 
Medici Revolving Credit Facility (4)
— — — — 
Total debt$2,309,308 $2,229,135 $1,871,492 $1,886,689 
(1)RenaissanceRe owns a noncontrolling economic interest in its joint venture DaVinci. Because RenaissanceRe controls a majority of DaVinci’s issued voting shares, the consolidated financial statements of DaVinci are included in the consolidated financial statements of RenaissanceRe. However, RenaissanceRe does not guarantee or provide credit support for DaVinci and RenaissanceRe’s financial exposure to DaVinci is limited to its investment in DaVinci’s shares and counterparty credit risk arising from reinsurance transactions.
(2)The 3.700% Senior Notes due 2025 were repaid in full at maturity on April 1, 2025.
(3)The 4.750% Senior Notes due 2025 (DaVinci) were repaid in full at maturity on May 1, 2025.
(4)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s issued voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions. If amounts are drawn under the Medici revolving credit facility, they are included in debt on the Company’s consolidated balance sheets.
Schedule of Outstanding Amounts Issued or Drawn under Credit Facilities
The outstanding amounts issued or drawn under each of the Company’s significant credit facilities are set forth below:
At September 30, 2025
Issued or Drawn
Revolving Credit Facility (1)
$— 
Medici Revolving Credit Facility (1) (2)
— 
Bilateral Letter of Credit Facilities
Secured
200,730 
Unsecured
297,268 
$497,998 
(1)At September 30, 2025, no amounts were issued or drawn under these facilities.
(2)RenaissanceRe owns a noncontrolling economic interest in Medici. Because RenaissanceRe controls all of Medici’s voting shares, the financial statements of Medici are included in RenaissanceRe’s consolidated financial statements. However, RenaissanceRe does not guarantee or provide credit support for Medici, and RenaissanceRe’s financial exposure to Medici is limited to its investment in Medici’s shares and counterparty credit risk arising from reinsurance transactions. If amounts are drawn under the Medici revolving credit facility, they are included in debt on the Company’s consolidated balance sheets.